comparemela.com

Latest Breaking News On - Alimera sciences inc - Page 1 : comparemela.com

Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
Alimera-sciences-inc
Listing-rule
Compensation-committee
Alimera-sciences
Inducement-plan
Inducement-awards
Nasdaq-global-market
Inducement-award
Nasdaq-listing-rule

Alimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Update

Alimera Sciences, Inc. (NASDAQ:ALIM – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 103,900 shares, a decline of 14.6% from the April 30th total of 121,700 shares. Based on an average daily trading volume, of 67,700 […]

United-states
Nasdaq
Vanguard-group-inc
Worth-venture-partners
Hillsdale-investment-management-inc
Hedge-funds-weigh-in-on-alimera-sciences
Alimera-sciences-inc
Maxim-group
Alimera-sciences-stock-down
Ancora-advisors
News-ratings-for-alimera-sciences-daily

AIGH Capital Management LLC Has $9.62 Million Stock Position in Alimera Sciences, Inc. (NASDAQ:ALIM)

AIGH Capital Management LLC lowered its stake in shares of Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,226,068 shares of the biopharmaceutical company’s stock after selling 146,504 […]

United-states
Alimera-sciences-profile
Alimera-sciences-stock-down
Nasdaq
Alimera-sciences-inc
Capital-management
Exchange-commission
Alimera-sciences
Maxim-group
Worth-venture-partners
News-ratings-for-alimera-sciences-daily

Q3 2024 EPS Estimates for Alimera Sciences, Inc. (NASDAQ:ALIM) Decreased by Analyst

Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) – HC Wainwright cut their Q3 2024 earnings per share estimates for shares of Alimera Sciences in a report issued on Thursday, May 16th. HC Wainwright analyst Y. Chen now anticipates that the biopharmaceutical company will earn ($0.01) per share for the quarter, down from their prior forecast […]

United-states
Alimera-sciences
Stonepine-capital-management
Hedge-funds-weigh-in-on-alimera-sciences
News-ratings-for-alimera-sciences-daily
Nasdaq
Maxim-group
Worth-venture-partners
Alimera-sciences-stock-performance
Vanguard-group-inc
Capital-management

Alimera Sciences' (ALIM) Buy Rating Reaffirmed at HC Wainwright

Alimera Sciences' (ALIM) Buy Rating Reaffirmed at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Vanguard-group-inc
Alimera-sciences-company-profile
Worth-venture-partners
Alimera-sciences
Hillsdale-investment-management-inc
Alimera-sciences-inc
Alimera-sciences-price-performance
News-ratings-for-alimera-sciences-daily
Institutional-trading-of-alimera-sciences
Maxim-group

vimarsana © 2020. All Rights Reserved.